Donata Vitagliano

The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells.

Giancarlo Troncone, Gennaro Chiappetta, G. Chiappetta, 2010, Endocrine-related cancer.

The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells.

Christine Stephan, Doriano Fabbro, Giorgio Caravatti, 2007, Cancer research.

Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice.

Horst Zitzelsberger, Kristian Unger, Giuliana Salvatore, 2012, Endocrine-related cancer.

The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes.

Teresa Guida, Alexander Levitzki, M. Santoro, 2002, Cancer research.

Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines

Erika Martinelli, F. Ciardiello, T. Troiani, 2013, Clinical Cancer Research.